Delivery Order SPE2DB22D2206-SPE2DB25FJA15
- Not listed
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Inlyta 5 mg tablets (60-count units) with a ceiling value of $11,895.72. This non-set-aside contract, awarded on July 21, 2025, utilizes firm fixed pricing and is scheduled for completion by August 11, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $10,710.96 firm fixed price delivery order is for the supply of INLYTA 1 MG TABLET 180S, a prescription medication, with a completion date of February 21, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania,...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at ten thousand six hundred eighty five dollars and ninety two cents ($10,685.92) by the Defense Logistics Agency Troop Support Medical to supply sixty (60) 5 mg tablets of INLYTA, an oral medication used to treat advanced kidney cancer. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period extending from...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,895.72, is for the delivery of INLYTA 5 MG TABLET 60S, a prescription medication. The contract is a firm fixed-price delivery order with a completion date of July 15, 2025. The contract is not set aside and was competed openly. AmerisourceBergen Drug Corp holds a significant...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $10,685.92 to Amerisourcebergen Drug Corporation to supply 60 boxes of 5 mg INLYTA tablets. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by September 12, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will perform under the contract. No set-aside designation or subcontractors were identified. The Defense Logistics...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical in the amount of $21,421.92. The delivery order is for 180 tablets of the 1 mg strength of INLYTA, an oral medication used to treat advanced kidney cancer. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required by January 2, 2024. No set-aside designation...
- This is a $11,039.62 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for the supply of 4,565,077,706 tablets of the prescription drug Inlyta (5 mg) to support federal government medical requirements. Amerisourcebergen is a major pharmaceutical distributor that holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December...
- This is a $23,847.20 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INLYTA 1 MG TABLET 180S, a pharmaceutical product, with a period of performance through June 10, 2025. Amerisourcebergen Drug Corp is also the holder of a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
- The Defense Logistics Agency Troop Support Medical awarded a $10,710.96 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 180 tablets of 1 mg INLYTA, an oncology medication. The prime contractor will deliver the pharmaceutical products from its Conshohocken, Pennsylvania facility to support the Defense Logistics Agency's medical supply chain programs. No major subcontractors or set aside designations were indicated. The delivery order was issued under an...
- This federal contract award, valued at $22,079.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the delivery of INLYTA 5 MG TABLET 60S, a pharmaceutical product, with a performance period through April 16, 2024. This award is a firm fixed price delivery order and does not have a set-aside designation. In addition to this specific delivery order,...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJA15Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order valued at $11,895.72 by the Defense Logistics Agency on July 22, 2025, for the supply of INLYTA 5 mg tablets in quantities of 60 units. The contract, which carries a firm fixed-price structure with an ultimate completion date of August 12, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million and extending through December 2026. This award was not issued under any set-aside designation, indicating it was competitively awarded in the open market. The delivery order supports the Defense Logistics Agency's medical supply chain operations, which provide pharmaceutical products to military healthcare systems and other federal customers. INLYTA, a prescription medication used in oncology treatment, will be distributed from AmerisourceBergen's Conshohocken, Pennsylvania facility. This transaction exemplifies the company's role as a critical vendor within the federal pharmaceutical procurement landscape, fulfilling specialized medical commodity requirements through flexible contracting vehicles that enable rapid delivery of essential medications to support defense and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.9k | 7/22/25 |